CD4 and type 1 diabetes mellitus: We also showed that an additional component of PLG/Ag-induced tolerance involved the sequestration of transgenic effector BDC-2.5 CD4+ T cells in the spleen, preventing them from trafficking to the pancreas and, thus, preventing overt T1D.